Considerations for Patient Monitoring Following CAR T and Bispecific Administration: Amir Fathi, MD

Considerations for Patient Monitoring Following CAR T and Bispecific Administration: Amir Fathi, MD

Amir Fathi, MD, leukemia specialist at Massachusetts General Hospital, discusses the importance of advocacy by both patients and their treatment team and key distinct toxicities that require vigilance.